Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nathanial R. Eddy
Observed names:
Eddy, Nathanial Reed,
N Eddy,
Nathanial Eddy
Institution:
Bristol-Myers Squibb (United States)
Observed institutions:
Bristol-Myers Squibb (United States),
Center for Theoretical Biological Physics,
Foundation Medicine (United States),
Rice University
ORCID:
0000-0002-0040-991X
Observed ORCID:
0000-0002-0040-991X
OpenAlex ID:
A5029622203
Order and disorder control the functional rearrangement of influenza hemagglutinin
2014
·
Xingcheng Lin
, Nathanial R. Eddy
, et al.
·
Proceedings of the National Academy of Sciences
·
61
PDF
Predicting EGFR mutational status from pathology images using a real-world dataset
2023
·
James J. Pao
, Mikayla Biggs
, et al.
·
Scientific Reports
·
37
PDF
Rotation-Activated and Cooperative Zipping Characterize Class I Viral Fusion Protein Dynamics
2018
·
Nathanial R. Eddy
, José N. Onuchic
·
Biophysical Journal
·
6
PDF
Abstract CT015: Clinical outcomes by genomic markers and ctDNA dynamics with perioperative nivolumab (NIVO) for resectable NSCLC from CheckMate 77T
2026
·
Tina Cascone
, Mark M. Awad
, et al.
·
Cancer Research
·
3
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer
2026
·
Tina Cascone
, Mark M. Awad
, et al.
·
Nature
·
1
PDF
Data from Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer
2026
·
Hossein Borghaei
, David Balli
, et al.
Supplementary Data 1 from Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer
2026
·
Hossein Borghaei
, David Balli
, et al.
A head-to-head comparison of abatacept and adalimumab in adults with early and dual seropositive rheumatoid arthritis plus HLA-DRB1 shared epitope: results from the randomised phase 3 AMPLIFIED trial
2026
·
Paul Emery
, Michael E Weinblatt
, et al.
·
Annals of the Rheumatic Diseases
AI-derived CD8⁺ cytotoxic T-cell immune signatures from baseline H&E images to predict immunotherapy benefit over chemotherapy in non–small cell lung cancer: Blinded validation in CheckMate-227 (CM227).
2026
·
Cristian Barrera
, Wiem Safta
, et al.
·
Journal of Clinical Oncology
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer
2026
·
Hossein Borghaei
, David Balli
, et al.
·
Clinical Cancer Research
Inhibition of platelet GPIbα augments immunotherapy response in liver cancer via remodeling of the intrahepatic immune landscape
2026
·
S Kam
, P Ramadori
, et al.
·
Zeitschrift für Gastroenterologie
Improvement of Thrombosis-relevant Biomarkers With Deucravacitinib Treatment in Patients With Systemic Lupus Erythematosus: Results From the Phase 2 Paisley Trial
2025
·
Christina Charles-Schoeman
, Brittany Weber
, et al.
·
The Journal of Rheumatology
Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod (P6-6.006)
2024
·
Ludwig Kappos
, Douglas Arnold
, et al.
·
Neurology
On the role of conformational flexibility in viral fusion mechanisms - fusion by disorder
2018
·
Eddy, Nathanial Reed
·
Rice Research Repository (Rice University)
Investigation of the pH Induced Conformational Rearrangement of Influenza Hemagglutinin
2016
·
Xingcheng Lin
, Jeffrey K. Noel
, et al.
·
Biophysical Journal
PDF
Study on the Dynamics of Influenza Hemagglutinin Based on Energy Landscape Theory
2014
·
Xingcheng Lin
, Nathanial R. Eddy
, et al.
·
Bulletin of the American Physical Society
Show more works
View as search
Works count:
16
Citation count:
108
H-index:
3
I10-index:
2
Year
Topic
Type
